[Immunologic and functional protein C determination in various internal diseases]. 1987

K H Zurborn, and H Broers, and W Kirch, and N Jäger, and H D Bruhn
I. Medizinische Universitätsklinik, Abteilung Innere Medizin, Kiel.

A new practicable and precise functional protein C evaluation test is based on the activation of protein C by a snake venom activator and determination of PC activity by its property to prolong the aPTT in a clotting assay (VK = 1.9% and 4% for intra- and interassay variance respectively). In 40 healthy controls there was a good correlation (r = 0.74) between the functional and immunological (ELISA) evaluation. In 123 patients with both evaluation methods but more pronounced with the measurement of the protein C activity a significant protein C deficiency was found in the patient groups with disseminated solid tumors, inflammatory diseases and myocardial infarction. Besides detection of hereditary PC deficiency Type II (generation of functionally abnormal PC) the functional assay profits by recording PC inhibitor complexes and otherwise dysfunctional PC in DIC. Thus, in patients with hematological neoplasias, only protein C activity was significantly decreases. Decrease of PC activity was more pronounced compared to PC Ag in liver disease indicating synthesis of functionally deficient PC, and in oral anticoagulant treatment due to detection of PIVKA-PC.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D008107 Liver Diseases Pathological processes of the LIVER. Liver Dysfunction,Disease, Liver,Diseases, Liver,Dysfunction, Liver,Dysfunctions, Liver,Liver Disease,Liver Dysfunctions
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D011486 Protein C A vitamin-K dependent zymogen present in the blood, which, upon activation by thrombin and thrombomodulin exerts anticoagulant properties by inactivating factors Va and VIIIa at the rate-limiting steps of thrombin formation.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

K H Zurborn, and H Broers, and W Kirch, and N Jäger, and H D Bruhn
January 1967, Archiv fur Gynakologie,
K H Zurborn, and H Broers, and W Kirch, and N Jäger, and H D Bruhn
November 1965, Munchener medizinische Wochenschrift (1950),
K H Zurborn, and H Broers, and W Kirch, and N Jäger, and H D Bruhn
January 1960, Polskie Archiwum Medycyny Wewnetrznej,
K H Zurborn, and H Broers, and W Kirch, and N Jäger, and H D Bruhn
January 1957, Il Friuli medico,
K H Zurborn, and H Broers, and W Kirch, and N Jäger, and H D Bruhn
March 1958, Minerva dermatologica,
K H Zurborn, and H Broers, and W Kirch, and N Jäger, and H D Bruhn
July 1965, Casopis lekaru ceskych,
K H Zurborn, and H Broers, and W Kirch, and N Jäger, and H D Bruhn
February 1968, Deutsche medizinische Wochenschrift (1946),
K H Zurborn, and H Broers, and W Kirch, and N Jäger, and H D Bruhn
January 1982, Laboratornoe delo,
K H Zurborn, and H Broers, and W Kirch, and N Jäger, and H D Bruhn
October 1957, Journal of immunology (Baltimore, Md. : 1950),
K H Zurborn, and H Broers, and W Kirch, and N Jäger, and H D Bruhn
January 1965, Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina,
Copied contents to your clipboard!